Main > NEUROLOGY. > Epilepsy. Treat. > GabaPentin (GABA Agonist) > ((1-NH2-Me)-1-Cyclohexane-CH2CO2H)) > Co.: IL. T (Generic Capsule/Patent) > Patent > Assignee, Claims, No. Etc

Product Israel. T. No. 03

PATENT NUMBER This data is not available for free
PATENT GRANT DATE September 2, 2003
PATENT TITLE Process for production of gabapentin intermediate

PATENT ABSTRACT The invention relates to a novel process for producing a the intermediary compound .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide. The process includes the steps of reacting a ketone such as cyclohexanone with ethylcyanoacetate in the presence of ammonium hydroxide
PATENT INVENTORS This data is not available for free
PATENT ASSIGNEE This data is not available for free
PATENT FILE DATE October 26, 2001
PATENT REFERENCES CITED Holder, R. W. et al., "Geminate-Substituted Cyclopentadienes. 1. Synthesis of 5,5-Dialkylcyclopentadienes via 4,4-Dialkylcyclopent-2-en-1-ones", J. Org. Chem. 1982, vol. 47, pp. 1445-1451.
Thorpe et al.; paper entitled, The Formation and Reactions of Imino Compounds: Part XVIII. The Condensation of cycloHexanones with Cyanoacetamide Involving the Displacement of an Alkyl Group. J. Chem. Soc. 1913, pp. 1586-1600.
Vogel, A.I., paper entitled Physical Properties and Chemical Constitution: Part II. Esters of .beta..beta.-Substituted Glutaric Acids. J. Chem. Soc., 1934, pp. 1758-1765.
PATENT PARENT CASE TEXT This data is not available for free
PATENT CLAIMS What is claimed is:

1. A process for producing a compound of formula I ##STR4##

comprising reacting a ketone with ethylcyanoacetate in the presence of ammonium hydroxide.

2. The process of claim 1, wherein the ketone is cyclohexanone.

3. The process of claim 1, wherein the reaction takes place in an aqueous environment.

4. The process of claim 1, further comprising a solvent.

5. The process of claim 4, in which the solvent is methanol.

6. The process of claim 4, in which the solvent is ethanol.

7. The process of claim 1, wherein the reaction is substantially complete within 24 hours.

8. The process of claim 1, further comprising adding water.

9. The process of claim 1, wherein the ratio of ethylcyanoacetate to cyclohexanone is in the range of 1:0.5 to 4:2.

10. A process for producing a compound of formula I comprising reacting cyclohexanone and ethylcyanoacetate in the presence of ammonium hydroxide.

11. A process for producing .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide comprising reacting cyclohexanone and ethylcyanoacetate in the presence of ammomiun hydroxide.

12. A process for producing a compound of formula I ##STR5##

the process comprising reacting a ketone with at least one ester of cyanoacetate acid in the presence of ammonium hydroxide.

13. The process of claim 12, wherein the at least one ester of cyanoacetate is methylcyanoacetate.
--------------------------------------------------------------------------------

PATENT DESCRIPTION FIELD OF THE INVENTION

The present invention relates to a compound that is used as an intermediate in the production of gabapentin, and a process for production thereof. More particularly, the present invention relates to .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide, and a process for manufacturing .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide.

BACKGROUND OF THE INVENTION

Gabapentin, 1-(aminomethyl)-1-cyclohexaneacetic acid, has the chemical structure of formula II: ##STR1##

Gabapentin is use for treating cerebral diseases such as epilepsy, faintness attacks, hypokinesis and cranial traumas. U.S. Pat. No. 4,024,175 to Satzinger et al., incorporated herein by reference, discloses that gabapentin of formula (IT) shows hypothermal and, in some cases, narcosis-potentiating or sedating properties as well as protective effect against cardiozole cramp in animals. Gabapentin is the active ingredient in Neurontin, marketed by Warner Lambert, and approved by the Food and Drug Administration as an anti-epileptic, anti-seizure, or anti-convulsant medication. As such, there has been a need for producing pure and stable gabapentin.

In one process for the preparation of gabapentin, an intermediary, .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide (formula I) ##STR2##

is produced by the Guareschi reaction in the following manner. Cyclohexanone and ethylcyanoacetate are reacted in an anhydrous environment in the presence of gaseous ammonia dissolved in ethanol. The reaction is represented as ##STR3##

The Guareschi reaction is inefficient as the reaction requires at least 48 hours to proceed to completion, and more typically between 48-168 hours for completion. In addition, current environmental regulations make it impractical to produce gaseous NH.sub.3 in ethanol on a large scale.

SUMMARY OF THE INVENTION

The present invention relates to a process for producing .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide (formula I) by reacting cyclohexanone and ethylcyanoacetate in the presence of ammonium hydroxide. The process of the present invention can be substantially completed in less than 24 hours. The reaction of the present invention can be processed in an aqueous environment and may include at least one solvent. The solvent can be methanol, ethanol or any similar solvent not having adverse affect on the reaction. Most importantly, a reaction of the present invention need not be conducted in an anhydrous environment.

DETAILED DESCRIPTION

We have discovered that contrary to previous practice in the art, the Guareschi reaction may be performed in the presence of water. Consequently, gaseous NH.sub.3 can be replaced in the reaction of .alpha.,.alpha.',dicyano-.beta.,.beta.-pentamethyleneglutarimide by, for example, an aqueous solution of ammonium hydroxide. Such aqueous solutions are significantly easier to handle since they avoid many of the environmental concerns that would arise from handling gaseous NH.sub.3 in ethanol.

Accordingly, in one embodiment of the invention a ketone is condensed with ethylcyanoacetate in the presence of ammonium hydroxide. In another embodiment of the invention, the ketone is cyclohexanone.

A reaction according to the present invention is substantially complete in less than 36 to 48 hours. In one embodiment of the invention, the reaction process is substantially completed in 24 to 36 hours. In a preferred embodiment, a reaction according to the present invention is substantially completed in less than 24 hours.

In one embodiment of the present invention, a molar ratio of ethylcyanoacetate:ketone is in the range of 1:0.5 to 4:2. In a preferred embodiment of the present invention, a molar ratio of ethylcyanoacetate:cyclohexanone is 2:1.

The organic solvent used in the Guareschi reaction can be an alcohol or another polar solvent. In a preferred embodiment the solvents are be methanol and ethanol. In addition, esters of cyanoacetate acid, such as for example, methylcyanoacetate can be used to replace ethylcyanoacetate in the Guareschi reaction.

PATENT EXAMPLES available on request
PATENT PHOTOCOPY available on request

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back